Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001193125-26-108982·EUPRAXIA PHARMACEUTICALS INC.
Schedule 13D ownership disclosure
EUPRAXIA PHARMACEUTICALS INC
Common Shares, no par value · CUSIP: 29842P105
Event date: 2026-03-13
- Filing-level shares
- 5,843,215
- Percent of class
- 9.0%
- Joseph S. FreedmanReported CIK 0002043590
Shares: 5,843,215 · Class: 9.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-108982
- Form type
- SCHEDULE 13D/A
- Filer
- EUPRAXIA PHARMACEUTICALS INC.
- CIK
- CIK 1581178
- Filed
- Mar 16, 2026
- Reporting period
- Mar 13, 2026
- Description
- Schedule 13D beneficial ownership